OLIVARES is a world-class IP law firm who represents some of the world’s biggest brands. We receive numerous awards and accolades every year from industry magazines and peer reviews due to a combination of long established trust, the highly personalized service we provide for our clients and a history of precedent setting success in patents, trademarks, copyrights, regulatory, administrative and constitutional law. We leverage our nearly 50 years of experience to offer a full range of IP, regulatory, administrative and some corporate law services, across all industries.
Much of OLIVARES’ strength and uniqueness comes from our sustained efforts to change and improve IP regulation in Mexico. The IP system is not always predictable and so we constantly challenge the system to improve it, and thus create IP protection that is less open to question in litigation.
In patent work our firm has the most diverse range of engineers in the Latin American market, allowing us to better navigate extremely technical issues with a more strategic approach than a traditional general practice firm. We have filed over 14,000 patents in the last ten years and the high level of education of our attorneys permits us to file both high quantities and qualities of patents.
In trademarks we have more recommendations from industry publications than any other firm and a fierce record of enforcement and litigation success.
In regulatory and administrative law we are breaking new ground and helping companies enforce rights granted by international treaties that are currently not being adjudicated adequately in Mexico. Further, the regulatory system in Mexico is complex to navigate and we have become experts in ensuring our clients fulfill all their regulatory obligations.
Our repeated success in litigation leads clients to us when other firms have failed. Companies and outside counsel often come to us when they have failed in the first round of patent, trademark, and copyright related litigation. The size and depth of our expertise is unparalleled in the Mexican market.
Dedicated Industry Groups
Other Industry Representation of Our Clients:
There is no doubt that COVID-19 has impacted almost every aspect of our lives. Due to the ongoing health crisis, among other efforts, governments have implemented measures expecting to break high rates of infection while trying to adapt the regulatory landscape to respond to the new virus and continuing to attend other illnesses. Moreover, the vaccination process has increased discussions over human rights, from right to health to patent rights. An equitable and global distribution of the vaccine will…
Key facts about biosimilars and biologics in Mexico. Prepared in association with Olivares, a leading global law firm, this is an extract from The Pharma Legal Handbook: Mexico, available to purchase here for GBP 99. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, biosimilars are not considered the same as generic medicines. Biosimilars are regulated by specific provisions within the sanitary legislation. The Mexican General Health Law defines a “biologic product” as any substance…
Key facts about Localization in Mexico. Prepared in association with Olivares, a leading global law firm, this is an extract from The Pharma Legal Handbook: Mexico, available to purchase here for GBP 99. 1. Are there any rules or regulations requiring and/or encouraging localization in your country? What is the legal framework defining these localization rules and policies? Largely, there are no specific rules or regulations requiring and/or encouraging localization in Mexico. Thus, there is no legal framework defining localization…